PubMed:32560744 / 0-364 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":187,"end":195},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":187,"end":195},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":14,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":197,"end":198},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":221,"end":222},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":242,"end":243},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5","span":{"begin":271,"end":281},"obj":"http://purl.obolibrary.org/obo/BFO_0000030"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":68,"end":70},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":13},"obj":"Sentence"},{"id":"T2","span":{"begin":14,"end":196},"obj":"Sentence"},{"id":"T3","span":{"begin":197,"end":270},"obj":"Sentence"},{"id":"T4","span":{"begin":271,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"chenxin_473849_800_3","denotations":[{"id":"T2","span":{"begin":187,"end":195},"obj":"DP"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}

{"project":"yangbin123xm_800_3","denotations":[{"id":"T1","span":{"begin":187,"end":195},"obj":"DP"}],"text":"AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.\nOBJECTIVES: Phase I - To determine the optimal dose of each candidate (or combination of cand"}